Related Experiment Video
Updated: Jun 23, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Asiaticoside Inhibits Growth and Metastasis in Non-Small Cell Lung Cancer by Disrupting EMT via Wnt/β-Catenin Pathway
Yanan Zhang1, Jiangyong Liu2, Gang Yang3
1Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Abstract:
Non-small cell lung cancer (NSCLC) is the primary inducer of cancer-related death worldwide. Asiaticoside (ATS) is a triterpenoid saponin that has been indicated to possess an antitumor activity in several malignancies. Nonetheless, its detailed functions in NSCLC remain unclarified. In this study, NSCLC cells were exposed to various doses of ATS. Functional experiments were employed to estimate the ATS effect on NSCLC cell behaviors. Western blotting was implemented for protein expression evaluation. A xenograft mouse model was established to assess the ATS effect on NSCLC in vivo. The results showed that ATS restrained NSCLC cell proliferation, cell cycle progression, migration, and invasiveness. ATS reversed TGF-β-induced promotion in epithelial-mesenchymal transition (EMT). Mechanistically, ATS inhibited Wnt/β-catenin signaling in NSCLC. Upregulating β-catenin restored ATS-mediated suppression of NSCLC cell aggressiveness. Moreover, ATS administration repressed tumorigenesis in tumor-bearing mice. In conclusion, ATS represses growth and metastasis in NSCLC by blocking EMT via the inhibition of Wnt/β-catenin signaling.
Insights
Asiaticoside (ATS) inhibits non-small cell lung cancer (NSCLC) growth and metastasis. This natural compound blocks epithelial-mesenchymal transition (EMT) by suppressing Wnt/β-catenin signaling, offering a potential therapeutic strategy for NSCLC.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
- Asiaticoside (ATS), a triterpenoid saponin, exhibits antitumor properties, but its role in NSCLC is not fully understood.
Purpose of the Study:
- To investigate the anti-cancer effects and underlying mechanisms of Asiaticoside (ATS) in non-small cell lung cancer (NSCLC).
Main Methods:
- In vitro studies on NSCLC cell lines assessing proliferation, cell cycle, migration, and invasiveness.
- Western blotting for protein expression analysis.
- In vivo xenograft mouse model to evaluate tumorigenesis.
Main Results:
- ATS significantly inhibited NSCLC cell proliferation, migration, and invasion.
- ATS reversed TGF-β-induced epithelial-mesenchymal transition (EMT) and suppressed Wnt/β-catenin signaling.
- Restoring β-catenin diminished the anti-cancer effects of ATS.
- ATS repressed tumor growth in vivo.
Conclusions:
- Asiaticoside (ATS) demonstrates significant anti-tumor and anti-metastatic potential in NSCLC.
- ATS functions by inhibiting EMT through the Wnt/β-catenin signaling pathway.
- ATS represents a promising therapeutic agent for NSCLC treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

